It will therefore be important to analyze further the relative contributions of SIK during cancer progression and define those instances where SIK operates under the control of TGFβ signaling or under the control of alternative signaling pathways, thus possibly promoting tumor progression or even suppressing tumorigenesis. Here, TGFB1 is linked to cancer.